- call +1-201-465-4211
- email sales@mrinsights.biz
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.
Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.
In this report, we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml
Scope of the Report:
The classification of erythropoietin includes epoetin-alfa, epoetin-beta, darbepoetin-alfa and others. The proportion of epoetin-alfa in 2016 is about 58.53%.
Erythropoietin is widely used for anemia and kidney disorders. The most proportion of Erythropoietin used in Kidney Disorders, and the market share in 2016 is 45.91%.
The worldwide market for Erythropoietin is expected to grow at a CAGR of roughly 5.9% over the next five years, will reach 9640 million US$ in 2024, from 7240 million US$ in 2019, according to a new study.
This report focuses on the Erythropoietin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Market Segment by Applications, can be divided into
Anemia
Kidney Disorders
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Erythropoietin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Erythropoietin, with price, sales, revenue and global market share of Erythropoietin in 2017 and 2018.
Chapter 3, the Erythropoietin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Erythropoietin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Erythropoietin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Erythropoietin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Erythropoietin Introduction
1.2 Market Analysis by Type
1.2.1 Epoetin-alfa
1.2.2 Epoetin-beta
1.2.3 Darbepoetin-alfa
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Anemia
1.3.2 Kidney Disorders
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Erythropoietin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Erythropoietin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Erythropoietin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Galenica
2.4.1 Business Overview
2.4.2 Erythropoietin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Galenica Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Emcure
2.5.1 Business Overview
2.5.2 Erythropoietin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Emcure Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Kyowa Hakko Kirin
2.6.1 Business Overview
2.6.2 Erythropoietin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kyowa Hakko Kirin Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 3SBio
2.7.1 Business Overview
2.7.2 Erythropoietin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 3SBio Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biocon
2.8.1 Business Overview
2.8.2 Erythropoietin Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biocon Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 LG Life Sciences
2.9.1 Business Overview
2.9.2 Erythropoietin Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 LG Life Sciences Erythropoietin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Erythropoietin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Erythropoietin Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Erythropoietin Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Erythropoietin Manufacturer Market Share in 2018
3.3.2 Top 6 Erythropoietin Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Erythropoietin Market Analysis by Regions
4.1 Global Erythropoietin Sales, Revenue and Market Share by Regions
4.1.1 Global Erythropoietin Sales and Market Share by Regions (2014-2019)
4.1.2 Global Erythropoietin Revenue and Market Share by Regions (2014-2019)
4.2 North America Erythropoietin Sales and Growth Rate (2014-2019)
4.3 Europe Erythropoietin Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Erythropoietin Sales and Growth Rate (2014-2019)
4.5 South America Erythropoietin Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Erythropoietin Sales and Growth Rate (2014-2019)
5 North America Erythropoietin by Country
5.1 North America Erythropoietin Sales, Revenue and Market Share by Country
5.1.1 North America Erythropoietin Sales and Market Share by Country (2014-2019)
5.1.2 North America Erythropoietin Revenue and Market Share by Country (2014-2019)
5.2 United States Erythropoietin Sales and Growth Rate (2014-2019)
5.3 Canada Erythropoietin Sales and Growth Rate (2014-2019)
5.4 Mexico Erythropoietin Sales and Growth Rate (2014-2019)
6 Europe Erythropoietin by Country
6.1 Europe Erythropoietin Sales, Revenue and Market Share by Country
6.1.1 Europe Erythropoietin Sales and Market Share by Country (2014-2019)
6.1.2 Europe Erythropoietin Revenue and Market Share by Country (2014-2019)
6.2 Germany Erythropoietin Sales and Growth Rate (2014-2019)
6.3 UK Erythropoietin Sales and Growth Rate (2014-2019)
6.4 France Erythropoietin Sales and Growth Rate (2014-2019)
6.5 Russia Erythropoietin Sales and Growth Rate (2014-2019)
6.6 Italy Erythropoietin Sales and Growth Rate (2014-2019)
7 Asia-Pacific Erythropoietin by Country
7.1 Asia-Pacific Erythropoietin Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Erythropoietin Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Erythropoietin Revenue and Market Share by Country (2014-2019)
7.2 China Erythropoietin Sales and Growth Rate (2014-2019)
7.3 Japan Erythropoietin Sales and Growth Rate (2014-2019)
7.4 Korea Erythropoietin Sales and Growth Rate (2014-2019)
7.5 India Erythropoietin Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Erythropoietin Sales and Growth Rate (2014-2019)
8 South America Erythropoietin by Country
8.1 South America Erythropoietin Sales, Revenue and Market Share by Country
8.1.1 South America Erythropoietin Sales and Market Share by Country (2014-2019)
8.1.2 South America Erythropoietin Revenue and Market Share by Country (2014-2019)
8.2 Brazil Erythropoietin Sales and Growth Rate (2014-2019)
8.3 Argentina Erythropoietin Sales and Growth Rate (2014-2019)
8.4 Colombia Erythropoietin Sales and Growth Rate (2014-2019)
9 Middle East and Africa Erythropoietin by Countries
9.1 Middle East and Africa Erythropoietin Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Erythropoietin Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Erythropoietin Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Erythropoietin Sales and Growth Rate (2014-2019)
9.3 Turkey Erythropoietin Sales and Growth Rate (2014-2019)
9.4 Egypt Erythropoietin Sales and Growth Rate (2014-2019)
9.5 Nigeria Erythropoietin Sales and Growth Rate (2014-2019)
9.6 South Africa Erythropoietin Sales and Growth Rate (2014-2019)
10 Global Erythropoietin Market Segment by Type
10.1 Global Erythropoietin Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Erythropoietin Sales and Market Share by Type (2014-2019)
10.1.2 Global Erythropoietin Revenue and Market Share by Type (2014-2019)
10.2 Epoetin-alfa Sales Growth and Price
10.2.1 Global Epoetin-alfa Sales Growth (2014-2019)
10.2.2 Global Epoetin-alfa Price (2014-2019)
10.3 Epoetin-beta Sales Growth and Price
10.3.1 Global Epoetin-beta Sales Growth (2014-2019)
10.3.2 Global Epoetin-beta Price (2014-2019)
10.4 Darbepoetin-alfa Sales Growth and Price
10.4.1 Global Darbepoetin-alfa Sales Growth (2014-2019)
10.4.2 Global Darbepoetin-alfa Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Erythropoietin Market Segment by Application
11.1 Global Erythropoietin Sales Market Share by Application (2014-2019)
11.2 Anemia Sales Growth (2014-2019)
11.3 Kidney Disorders Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Erythropoietin Market Forecast (2019-2024)
12.1 Global Erythropoietin Sales, Revenue and Growth Rate (2019-2024)
12.2 Erythropoietin Market Forecast by Regions (2019-2024)
12.2.1 North America Erythropoietin Market Forecast (2019-2024)
12.2.2 Europe Erythropoietin Market Forecast (2019-2024)
12.2.3 Asia-Pacific Erythropoietin Market Forecast (2019-2024)
12.2.4 South America Erythropoietin Market Forecast (2019-2024)
12.2.5 Middle East and Africa Erythropoietin Market Forecast (2019-2024)
12.3 Erythropoietin Market Forecast by Type (2019-2024)
12.3.1 Global Erythropoietin Sales Forecast by Type (2019-2024)
12.3.2 Global Erythropoietin Market Share Forecast by Type (2019-2024)
12.4 Erythropoietin Market Forecast by Application (2019-2024)
12.4.1 Global Erythropoietin Sales Forecast by Application (2019-2024)
12.4.2 Global Erythropoietin Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Erythropoietin Picture
Table Product Specifications of Erythropoietin
Figure Global Sales Market Share of Erythropoietin by Types in 2018
Table Erythrop
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
